Patterns of extranodal involvement predict early clinical failure in patients with follicular lymphoma (FL), according to a newly published study that looked at this variable in a large series of ...
Allogeneic hematopoietic stem cell transplantation in a cohort of 314 advanced lymphoma patients. a-NHL 97.8 76.1 50.9 99.3 i-NHL 96.3 90.2 82.3 98.1 This is an ASCO Meeting Abstract from the 2014 ...
Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.
Paediatric lymphoma is the third most common childhood malignancy and comprises 15% of childhood cancer and this condition is not only observed in the Paediatric practice in developed countires but ...
Expert Rev Hematol. 2009;2(3):261-276. © 2009 Expert Reviews Ltd. *No randomization regarding PET-response adapted therapy. ABVD = Doxorubicin, bleomycin ...
Increased rituximab (R) doses and effect on risk of elderly male patients with aggressive CD20+ B-cell lymphomas: Results from the SEXIE-R-CHOP-14 trial of the DSHNHL. This is an ASCO Meeting Abstract ...
The research group at the University of Wisconsin-Madison. From left to right: Timothy Perk, Alison Roth, Peter Ferjančič, Robert Jeraj, Daniel Huff, Brayden Schott, Ali Deatsch, Victor Santoro ...
Certain quantitative PET parameters can help clinicians predict how well patients with Hodgkin’s lymphoma will react to their treatment, according to preliminary results from a study conducted in the ...
PET has become a cornerstone procedure in modern lymphoma management. This paper reviews, from a clinical point of view, the evidence for using PET in the different subtypes of lymphoma and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback